Paclitaxel anticancer activity is enhanced by the MEK 1/2 inhibitor PD98059 in vitro and by PD98059-loaded nanoparticles in BRAFV600E melanoma-bearing mice

Publication date: Available online 10 July 2021Source: International Journal of PharmaceuticsAuthor(s): Aml I. Mekkawy, Youssef W. Naguib, Suhaila O. Alhaj-Suliman, Emad I. Wafa, Kareem Ebeid, Timothy Acri, Aliasger K. Salem
Source: International Journal of Pharmaceutics - Category: Drugs & Pharmacology Source Type: research